SGS Capacity Update October 2025: Analytical Services

Backed by 30 years of global pharmaceutical testing expertise, SGS provides a complete range of bioanalytical solutions, including Method development, validation and transfer; PK and PD Bioanalysis, ELISA and multiplex assays, bioassays, Immunogenicity testing, and more.

Our comprehensive bioanalytical testing services from preclinical to early and late clinical phases include:

• Pharmacokinetics (small molecules, biologics, biosimilars)
• Biomarkers (PD) (soluble and cellular biomarkers)
• Immunogenicity (screening, confirmatory, titration characterisation and neutralising anti-drug antibody assays)
• Method transfer, development and validation for small molecules, biologics, biosimilars and biomarkers
• ELISA and multiplex assays for biomarkers
• Cell-based assays (cellular biomarkers, receptor occupancy, neutralising anti-drug antibody assays, immunophenotyping)
• Hybrid approach LBA/LC-MS/MS
• Discovery Services (i.e. Immunotox, non-regulatory preclinical studies)

Learn how SGS can help you control costs, increase efficiency and accelerate your clinical programs with our globally-integrated bioanalytical solutions.

Explore the importance of analytical comparability and use of orthogonal methods through out the biosimilar development.